Novonesis AS

Director's Dealing • Jan 27, 2015

January 27, 2015

In accordance with Section 28a of the Danish Securities Trading Act, Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B.

Name	Thomas Nagy
Relation/category of close relation	EVP, Supply Operations
Trading date	23.01.2015
Market	Nasdaq OMX Copenhagen A/S
Character of transaction	Sell of shares
Volume of transaction buy(+)/ sell (-)	-20,000
Value of transaction (DKK)	6,016,009.40 DKK

Name	Thomas Nagy
Relation/category of close relation	EVP, Supply Operations
Trading date	23.01.2015
Market	Nasdaq OMX Copenhagen A/S
Character of transaction	Sell of shares
Volume of transaction buy(+)/ sell (-)	-2,680
Value of transaction (DKK)	808,083.50 DKK

Name	Per Falholt
Relation/category of close relation	EVP, R&D
Trading date	27.01.2015
Market	Nasdaq OMX Copenhagen A/S
Character of transaction	Buy of shares from exercise of stock options
Volume of transaction buy(+)/ sell (-)	+121,215
Value of transaction (DKK)	10,739,649 DKK

Contact information

Investor Relations:

Thomas Bomhoff (DK)	+45 3077 1226	tsbm@novozymes.com
Klaus Sindahl (DK)	+45 5363 0134	ksdh@novozymes.com
Martin Riise (USA)	+1 919 649 2565	mrsn@novozymes.com
Media Relations:
Rene Tronborg (DK)	+45 3077 2274	retr@novozymes.com
Frederik Bjoerndal (Europe)	+44 7976138265	tfbh@novozymes.com
Paige Donnelly (USA)	+1 919 218 4501	pagd@novozymes.com
Zhang Zheng (China)	+86 137 0117 0610	zhz@novozymes.com
Henrique Pellini (Brazil)	+55 41 9288 0282	hqp@novozymes.com
Kanak Angirish (India)	+91 803 059 3500	kna@novozymes.com

Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources. Read more at www.novozymes.com.